Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Cash & Equivalents (2017 - 2025)

Historic Cash & Equivalents for MedWellAI (MWAI) over the last 12 years, with Q3 2025 value amounting to $223221.0.

  • MedWellAI's Cash & Equivalents fell 7022.71% to $223221.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $223221.0, marking a year-over-year decrease of 7022.71%. This contributed to the annual value of $401310.0 for FY2025, which is 59412.78% up from last year.
  • According to the latest figures from Q3 2025, MedWellAI's Cash & Equivalents is $223221.0, which was down 7022.71% from $401310.0 recorded in Q2 2025.
  • MedWellAI's Cash & Equivalents' 5-year high stood at $2.1 million during Q2 2021, with a 5-year trough of $27452.0 in Q4 2023.
  • Its 5-year average for Cash & Equivalents is $366958.0, with a median of $234519.0 in 2024.
  • In the last 5 years, MedWellAI's Cash & Equivalents skyrocketed by 3132377.53% in 2021 and then tumbled by 7947.33% in 2022.
  • MedWellAI's Cash & Equivalents (Quarter) stood at $155729.0 in 2021, then crashed by 44.2% to $86891.0 in 2022, then crashed by 68.41% to $27452.0 in 2023, then surged by 754.29% to $234519.0 in 2024, then dropped by 4.82% to $223221.0 in 2025.
  • Its Cash & Equivalents was $223221.0 in Q3 2025, compared to $401310.0 in Q2 2025 and $482221.0 in Q1 2025.